Counterpoint Mutual Funds LLC Has $3.16 Million Stock Holdings in Helen of Troy Limited $HELE

Counterpoint Mutual Funds LLC boosted its stake in Helen of Troy Limited (NASDAQ:HELEFree Report) by 882.6% during the third quarter, Holdings Channel reports. The institutional investor owned 125,416 shares of the company’s stock after buying an additional 112,652 shares during the period. Helen of Troy comprises approximately 0.2% of Counterpoint Mutual Funds LLC’s investment portfolio, making the stock its 13th biggest position. Counterpoint Mutual Funds LLC’s holdings in Helen of Troy were worth $3,160,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. AXQ Capital LP bought a new stake in shares of Helen of Troy during the third quarter worth approximately $253,000. Villanova Investment Management Co LLC grew its stake in shares of Helen of Troy by 78.0% in the third quarter. Villanova Investment Management Co LLC now owns 53,854 shares of the company’s stock valued at $1,357,000 after acquiring an additional 23,604 shares in the last quarter. Semanteon Capital Management LP bought a new position in Helen of Troy during the third quarter worth about $576,000. Pzena Investment Management LLC increased its position in Helen of Troy by 2.6% during the third quarter. Pzena Investment Management LLC now owns 1,010,756 shares of the company’s stock worth $25,471,000 after acquiring an additional 25,425 shares during the period. Finally, M&G PLC raised its stake in Helen of Troy by 3.3% in the 3rd quarter. M&G PLC now owns 330,309 shares of the company’s stock worth $8,258,000 after purchasing an additional 10,623 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on HELE shares. Canaccord Genuity Group set a $22.00 target price on shares of Helen of Troy in a research report on Friday, January 9th. Zacks Research downgraded Helen of Troy from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 20th. Weiss Ratings restated a “sell (d-)” rating on shares of Helen of Troy in a research note on Monday, December 29th. CJS Securities raised Helen of Troy to a “strong-buy” rating in a report on Thursday, December 11th. Finally, UBS Group cut their target price on Helen of Troy from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Helen of Troy currently has a consensus rating of “Hold” and an average price target of $22.00.

Get Our Latest Research Report on Helen of Troy

Helen of Troy Stock Performance

Helen of Troy stock opened at $17.39 on Tuesday. The company has a quick ratio of 0.90, a current ratio of 1.81 and a debt-to-equity ratio of 1.02. The stock has a market cap of $401.19 million, a PE ratio of -0.50 and a beta of 0.81. Helen of Troy Limited has a 12-month low of $16.29 and a 12-month high of $60.42. The business’s 50-day moving average price is $19.13 and its two-hundred day moving average price is $20.88.

Helen of Troy (NASDAQ:HELEGet Free Report) last posted its earnings results on Thursday, January 8th. The company reported $1.71 EPS for the quarter, missing analysts’ consensus estimates of $1.75 by ($0.04). The company had revenue of $512.83 million during the quarter, compared to the consensus estimate of $502.42 million. Helen of Troy had a positive return on equity of 8.33% and a negative net margin of 43.97%.The firm’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company posted $2.67 EPS. Helen of Troy has set its FY 2026 guidance at 3.250-3.75 EPS and its Q4 2026 guidance at 0.530-1.030 EPS. As a group, analysts expect that Helen of Troy Limited will post 6.46 earnings per share for the current fiscal year.

Helen of Troy Profile

(Free Report)

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.

Featured Stories

Want to see what other hedge funds are holding HELE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helen of Troy Limited (NASDAQ:HELEFree Report).

Institutional Ownership by Quarter for Helen of Troy (NASDAQ:HELE)

Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.